Intravenous Engraftment
Intravenous Engraftment - Related Videos
07:22
Discontinuing Intravenous Fluids and a Peripheral Intravenous Line
0 Views •
2023
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT Intravenous (IV) fluid administration and peripheral IV catheters (PIVs) may be discontinued for a number of reasons. The most common reason for discontinuing IV fluids is that the patient has returned to normal body fluid volume (euvolemia) and is able to maintain adequate oral fluid intake or is being discharged from the hospital. In addition, the Centers for Disease Control Guidelines...
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
0 Views •
Cited by 1 •
2018
Mantle cell lymphoma (MCL) is a difficult to treat B cell disorder and it is equally difficult to establish a xenograft mouse model of primary MCL to study and develop therapeutics. Here, we describe the successful establishment of MCL xenografts in mice to help understand its underlying biology.
04:36
Adenocarcinoma Engraftment: A Method to Implant Cancer Cells into the Murine Lungs
0 Views •
2023
This video describes a method to engraft lung adenocarcinoma cells in murine lungs by preconditioning the airways with fibrosis-inducing agent–bleomycin. This method significantly enhances orthotopic engraftment of lung cancer cells into murine...
11:39
Peripheral Intravenous Catheter Insertion
0 Views •
2023
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT The purpose of peripheral intravenous catheter (PIV) insertion is to infuse medications, perform intravenous (IV) fluid therapy, or inject radioactive tracers for special examination procedures. Placing a PIV is an invasive procedure and requires the use of an aseptic, no-touch technique. Common IV venipuncture sites are the arms and hands in adults and the feet in children. According to...
07:08
Assessing and Flushing a Peripheral Intravenous Line
0 Views •
2023
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT After peripheral intravenous (IV) access is initiated, it is important to assess and maintain the IV catheter according to institutional policies and nursing standards of practice. The regular assessment of the insertion site and the surrounding areas for signs of complications is necessary to prevent IV catheter complications, including infiltration, phlebitis, infection, extravasation, or...
FAQs
The CXCR4-CXCL12 chemokine pair helps infused hematopoietic stem and progenitor cells respond to signals from the bone marrow environment. This guidance supports their movement from the circulation toward marrow locations where they can establish themselves. Its role is important because successful localization places the cells near the supportive niches required for subsequent blood and immune cell production.
Marrow niches provide the local setting in which hematopoietic stem and progenitor cells adhere, proliferate, and differentiate. Adhesion helps retain the cells within the marrow rather than leaving them in circulation, while proliferation expands their contribution and differentiation generates mature blood lineages. These coordinated events determine whether cellular establishment leads to effective restoration of hematopoiesis.
Delayed or failed engraftment can produce persistent cytopenias, meaning reduced numbers of circulating blood cells. These abnormalities reflect inadequate restoration of blood cell production and can create serious infectious complications. In contrast, successful establishment of the infused cells supports immune reconstitution, so the timing and completeness of engraftment have direct consequences for vulnerability during recovery.
Following intravenous infusion, the cells first circulate through the recipient, then respond to marrow-directed chemokine signals. They move toward appropriate marrow locations, adhere to supportive niches, and begin proliferating. Subsequent differentiation produces mature blood lineages. This sequence connects the initial infusion with the later recovery of blood and immune cell production.
Intravenous engraftment underlies hematopoietic stem cell transplantation for conditions in which blood-forming or immune-cell production must be restored. The overview identifies leukemia, marrow failure, and primary immunodeficiencies as examples. In these settings, establishment of infused cells in the marrow can provide the cellular basis for renewed production across mature blood lineages.
Its immunological importance lies in restoring production of immune cells as part of broader hematopoietic recovery. Successful engraftment supports immune reconstitution and reduces prolonged vulnerability to infection. Conversely, delayed or failed establishment can maintain cytopenias and contribute to serious infectious complications, making engraftment a central outcome when evaluating recovery after transplantation.